Andrew B. Bindman, M.D., is executive vice president and chief medical officer for Kaiser Permanente.
In this role since 2020, Dr. Bindman is responsible for driving superior quality and equitable health outcomes through the integration of quality innovation, care delivery and research. He collaborates with the Permanente Medical Groups and the Permanente Federation to accelerate Kaiser Permanente’s quality strategy and improve the high-quality care provided to members and patients nationwide.
He works closely with clinical and operational leaders to establish common performance standards for quality and service, drive consistent adoption of key quality programs, and leverage data analytics and research across the enterprise. His areas of focus include advancing the quality outcomes that matter most to members and establishing equity, alongside quality and safety, as a fundamental metric for care. He is also the executive sponsor for the Kaiser Permanente Bernard J. Tyson School of Medicine.
Dr. Bindman previously spent more than 30 years as a tenured professor at the University of California, San Francisco where he practiced and taught internal medicine while conducting research in health access and outcomes that resulted in more than 200 published scientific articles. A noted policy advocate, he has held advisory and leadership roles for the U.S. House Energy and Commerce Committee, the U.S. Department of Health and Human Services, and the Agency for Healthcare Research and Quality, where he served as director.
Dr. Bindman is a graduate of Harvard College and the Mount Sinai School of Medicine. A board-certified general internist, he completed his residency in internal medicine at UCSF and was a Robert Wood Johnson Foundation Clinical Scholar at Stanford University.
He was elected to the National Academy of Medicine in 2015 where he currently serves on the organization’s board for health care services, chairs the workshops on diagnostic excellence, and is on the steering committee for developing a Health Care Artificial Intelligence Code of Conduct. In 2021, he was elected to the Association of American Physicians in recognition for his notable contributions to advancing scientific and practical medicine. In 2023, he was elected to be the vice chair of the National Quality Forum.